medline.ch Onkologie Urologische Tumoren

	Cell-free DNA whole-genomes reveal chromosomal rearrangements associated with heterogeneity and stem cell-like castration-resistant prostate cancer. medRxiv Roskes ML, Martinez-Fundichely A, Cohen S, Balaban M, Wong CK, Li W, Gonzalez TA, Tehim AB, Xu H, ElNaggar S, Myers M, Bareja R, Dorsaint P, Gorski K, Asad M, Assaad MA, Robinson BD, Sigouros M, Barnett E, Manohar J, Tagawa S, Nanus D, Molina A, Nauseef JT, Sternberg CN, Mosquera JM, Scher HI, Sboner A, Raphael BJ, Chen Y, Khurana E. PMID: 40630580 [PubMed]
	Evaluating PI-RADS lesions and clinically significant prostate cancer in Black and Asian men: a PREVENT randomized clinical trial secondary analysis. Res Sq Driscoll C, Handa N, Huang M, Murphy A, Hu J, Schaeffer E. PMID: 40630527 [PubMed]
	Mechanistic study of CTHRC1 in promoting Wilms' tumor progression by regulating M2-type tumor-associated macrophages polarization. J Transl Med Zhuo Y, Feng X, Zhang W, Du J, Sun X, Luo X, Wang W, Jiang H, Gu H. PMID: 40629408 [PubMed - indexed for MEDLINE]
	Successful Treatment of Growing Renal Angiomyolipomas With Low-Dose Everolimus in a School-Aged Child With Tuberous Sclerosis Complex. Nephrology (Carlton) Senoo S, Kanda S, Takizawa K, Terashima H, Kajiho Y, Harita Y. PMID: 40628370 [PubMed - indexed for MEDLINE]
	A prospective study of bladder volume assessment using ultrasound in prostate cancer radiotherapy: Comparison with cone-beam computed tomography (CBCT). Radiography (Lond) B, Kaczmarek K, Rado, Winiecki T, Bajon T. PMID: 40627993 [PubMed - as supplied by publisher]
	Geographical Differences in the Management and Outcomes of Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab After Progression on Platinum-Based Chemotherapy: Results From ARON-2 Study. JCO Glob Oncol Rizzo M, Soares A, Gupta S, Calabrò F, Takeshita H, Bourlon MT, Park SH, Giannatempo P, Myint ZW, Büttner T, Grande E, Fiala O, Santini D, Bamias A, Zakopoulou R, Buti S, Kanesvaran R, Rescigno P, Molina-Cerrillo J, Epstein I, Marques Monteiro FS, Massari F, Porta C, Bellmunt J, Santoni M. PMID: 40627820 [PubMed - indexed for MEDLINE]
	Male Breast Cancer After Kidney Transplant: Case Report and Literature Revue. Exp Clin Transplant Chaker H, Yaich S, Abid H, Khemiri S, Charfi S, Masmoudi M, Ben Hmida M, Boudawara T, Khanfir A, Kammoun K. PMID: 40626825 [PubMed - indexed for MEDLINE]
	Invasiveness or growth pattern in urothelial tumours. A perspective to rethink the current WHO classification. Pathologica Lee J, Choi S, Kwon GY. PMID: 40626668 [PubMed - indexed for MEDLINE]
	A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial: Erratum. J Urol Lazarovich A, Vigneswaran H, Palsdottir T, Eklund M, Discacciati A, Nordström T, Hubbard RA, Perlis N, Abern MR, Moreira DM, Yonover P, Chow AK, Watts K, Liss MA, Thoreson GR, Abreu AL, Sonn GA, Plym A, Wiklund F, Grönberg H, Murphy AB, Eggener S. PMID: 40626447 [PubMed]
	Evaluation of the changes in hydrogel spacer volume in patients treated with proton therapy for prostate cancer. BMC Urol Inoue K, Shinohara M, Saka T, Hirao Y, Shinohara Y, Higashikawa T, Yamamoto M. PMID: 40624549 [PubMed - indexed for MEDLINE]
	Clinicopathologic and prognosis of 30 patients with FH-deficient renal cell carcinoma: a single-center retrospective study. BMC Cancer Bai J, Huang J, Ye Y, Lin J, Wen Y, Cai Z, Chen P, Shangguan T, Zou G, Qiu Q, Chen R, Liu R, Cai W, Zhu S, Chen J, Li X. PMID: 40624460 [PubMed - indexed for MEDLINE]
	Real-world trends in the use and outcomes of novel androgen receptor signaling inhibitor therapy in patients with non-metastatic castration-resistant prostate cancer: a multicenter retrospective study. Int J Clin Oncol Yoneyama F, Fujita N, Kawashima Y, Shinohara M, Tabata R, Tanaka R, Oishi T, Miura H, Togashi K, Okita K, Horiguchi H, Tanaka T, Noro D, Suzuki Y, Sato S, Ohyama C, Hatakeyama S. PMID: 40624429 [PubMed - as supplied by publisher]
	Rectal spacer use and bowel, urinary, and sexual dysfunction diagnosis and related procedures among men receiving prostate radiotherapy: US county-level analysis. World J Urol Yu JB, Folkert MR, Sato R, Collins S, Hankins R, Mehta P, Bhattacharyya S, Ezekekwu E, Hamstra DA. PMID: 40624294 [PubMed - indexed for MEDLINE]
	Development and retrospective validation of an artificial intelligence system for diagnostic assessment of prostate biopsies: study protocol. BMJ Open Mulliqi N, Blilie A, Ji X, Szolnoky K, Olsson H, Titus M, Martinez Gonzalez G, Boman SE, Valkonen M, Gudlaugsson E, Kjosavik SR, Asenjo J, Gambacorta M, Libretti P, Braun M, Kordek R, , Hotakainen K, Väre P, Pedersen BG, Sørensen KD, Ulhøi BP, Rantalainen M, Ruusuvuori P, Delahunt B, Samaratunga H, Tsuzuki T, Janssen EAM, Egevad L, Kartasalo K, Eklund M. PMID: 40623883 [PubMed - indexed for MEDLINE]
	Diagnostic Accuracy of [(18)F]-DCFPyL PSMA PET/CT in Intermediate-Risk Prostate Cancer Undergoing Radical Prostatectomy: Is Pelvic Lymph Node Dissection Still Necessary? J Urol Eraky A, Tilu N, Ben-David R, Hug B, Jodka H, Agarwal Y, Sur H, Zhou M, Choudhary MK, Mehrazin R, Tewari A. PMID: 40623296 [PubMed - as supplied by publisher]
	Systematically identification of survival-associated eQTLs in a Japanese kidney cancer cohort. PLoS Genet Song X, Jin H, Li X, Yuan M, Yang H, Sato Y, Kume H, Ogawa S, Zhang C, Mardinoglu A. PMID: 40622919 [PubMed - indexed for MEDLINE]
	Comparison of perioperative outcomes between Bricker and Wallace anastomosis techniques in robotic-assisted radical cystectomy with intracorporeal diversion. World J Urol Carreno GL, Fu H, Messer J. PMID: 40622432 [PubMed - indexed for MEDLINE]
	Immunotherapy in metastatic prostate cancer. Ther Adv Med Oncol Dwyer L, Leslie C, Mellor R, Scheinberg T, Taylor RA, Horvath LG. PMID: 40621483 [PubMed]
	Interleukins as a potential link between obstructive sleep apnea and renal cell carcinoma. Contemp Oncol (Pozn) Sta, Maliszewska-Olejniczak K, Fiedorowicz M, Czarnecka AM, Kukwa W. PMID: 40620892 [PubMed]
	Preoperative systemic inflammatory biomarkers can improve recurrence prediction of non-muscle invasive bladder cancer after endoscopic resection - a prospective observational study. Contemp Oncol (Pozn) Bardowska K, Krajewski W, Ko, Ko, Bartoszek D, , Chorbi, Królicki T, Krajewska M, Szyde, Kami. PMID: 40620890 [PubMed]

Artikel 1 - 20 / 168662

Seite 1 von 8434

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung